The latest market analysis reveals a significant surge in the global single-photon emission computed tomography market, with a robust growth trajectory expected to continue over the next decade. According to FMI, the market size for single-photon emission computed tomography market reached US$ 2.28 Billion in 2021 and is anticipated to escalate to US$ 2.45 Billion by the end of 2022. This surge is attributed to the rising prevalence of cardiovascular diseases and the growing demand for advanced diagnostic technologies worldwide.
With an anticipated Compound Annual Growth Rate (CAGR) of 6.9% between 2022 and 2032, the single-photon emission computed tomography market is projected to attain a valuation of approximately US$ 4.76 Billion by 2032. This remarkable growth underscores the increasing reliance on single-photon emission computed tomography technology for non-invasive diagnostic imaging of metabolic processes, particularly in chronic illnesses.
Get Access to Sample Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-5826
Key Findings:
- Dominance of Single Imaging Gamma Cameras Segment: The single imaging gamma cameras segment emerged as the dominant force in the global single-photon emission computed tomography market, capturing a market share of about 75.5% in 2021. This segment is poised to maintain its dominance throughout the forecast period, reflecting its pivotal role in nuclear medicine
- Applications of SPECT in Disease Detection: single-photon emission computed tomography technology enables the production of 3-D images of functional processes within the human body, facilitating non-invasive diagnostic imaging of metabolic processes using short-lived radioisotopes. Its versatility in assessing metabolic and functional data of cells and organs is instrumental in disease detection and management.
- Market Expansion Through Enhanced Diagnostic Capabilities: The continuous evolution of single-photon emission computed tomography imaging systems, particularly in organic-specific or dual-modality systems, is anticipated to drive market expansion in the coming years. The focus on enhancing equipment’s diagnostic capabilities underscores the industry’s commitment to advancing healthcare outcomes globally.
Future Outlook:
As the global healthcare landscape evolves, the demand for advanced diagnostic technologies like single-photon emission computed tomography market is expected to soar. With its unparalleled ability to provide insights into metabolic processes and disease pathology, single-photon emission computed tomography market is poised to play a pivotal role in shaping the future of medical imaging.
Click Here to Request Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5826
The key trends driving the global single-photon emission computed tomography (SPECT) market are:
- Expanding applications: single-photon emission computed tomography is finding use in a wider range of medical fields, including cardiology, oncology, neurology, and more. This versatility is increasing demand for single-photon emission computed tomography systems.
- Advancements in radiopharmaceuticals: The development of new radiotracers that target specific organs and diseases is improving the accuracy and effectiveness of single-photon emission computed tomography scans.
- Rise of SPECT/CT scanners: Hybrid SPECT/CT scanners combine single-photon emission computed tomography with X-ray CT technology, providing more detailed information and improving diagnostic capabilities.
- Multimodality imaging: The trend towards combining single-photon emission computed tomography with other imaging techniques, such as MRI, is creating a more comprehensive picture of a patient’s condition.
- Technological advancements: Developments in instrumentation and information technology are making single-photon emission computed tomography scans faster, more efficient, and more user-friendly.
Key Companies Profiled:
- Bruker Corp.
- DDD-Diagnostic AS
- Digmed Corp.
- General Electric Co.
- Mediso Ltd.
- MiE GmbH
- MILabs BV
- Siemens Healthineers AG
- Spectrum Dynamics Medical Inc.
- GE Healthcare
- CardiArc
- Beijing Hamamatsu Photon Techniques INC.
- SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
- PNPMed
- NuCare Inc.
Direct Purchase of this Report: https://www.futuremarketinsights.com/checkout/5826
Key Market Segments Covered in Single-photon Emission Computed Tomography Industry Research:
By Product:
- Single Imaging Gamma Cameras
- SPECT/CT
By Application:
- Cardiology
- Oncology
- Neurology
- Others
By End User:
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa(MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube